vs
Portillo's Inc.（PTLO）与再鼎医药（ZLAB）财务数据对比。点击上方公司名可切换其他公司
Portillo's Inc.的季度营收约是再鼎医药的1.5倍（$185.7M vs $127.1M），再鼎医药同比增速更快（17.1% vs 0.6%），Portillo's Inc.自由现金流更多（$-9.2M vs $-26.7M），过去两年再鼎医药的营收复合增速更高（20.8% vs 5.8%）
Portillo's Inc.是总部位于美国芝加哥地区的休闲快餐连锁品牌，主打芝加哥风味美食，代表菜品包括芝加哥热狗、麦克斯韦街波兰香肠以及意式牛肉三明治。该品牌由迪克·波蒂略于1963年4月9日在伊利诺伊州维拉公园创立，最初门店名为“The Dog House”。
再鼎医药是一家创新生物制药企业，专注于肿瘤、自身免疫性疾病、感染性疾病等领域创新疗法的研发、生产与商业化，核心市场覆盖大中华区，与全球多家头部生物科技企业合作，为存在未被满足医疗需求的患者提供治疗方案。
PTLO vs ZLAB — 直观对比
营收规模更大
PTLO
是对方的1.5倍
$127.1M
营收增速更快
ZLAB
高出16.5%
0.6%
自由现金流更多
PTLO
多$17.5M
$-26.7M
两年增速更快
ZLAB
近两年复合增速
5.8%
损益表 — Q4 FY2025 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $185.7M | $127.1M |
| 净利润 | $6.3M | — |
| 毛利率 | — | 51.0% |
| 营业利润率 | 5.6% | -54.6% |
| 净利率 | 3.4% | — |
| 营收同比 | 0.6% | 17.1% |
| 净利润同比 | -49.5% | — |
| 每股收益（稀释后） | $0.08 | $-0.05 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收PTLOZLAB
| Q4 25 | $185.7M | $127.1M | ||
| Q3 25 | $181.4M | $115.4M | ||
| Q2 25 | $188.5M | $109.1M | ||
| Q1 25 | $176.4M | $105.7M | ||
| Q4 24 | $184.6M | $108.5M | ||
| Q3 24 | $178.3M | $101.8M | ||
| Q2 24 | $181.9M | $100.1M | ||
| Q1 24 | $165.8M | $87.1M |
净利润PTLOZLAB
| Q4 25 | $6.3M | — | ||
| Q3 25 | $1.2M | $-36.0M | ||
| Q2 25 | $8.7M | $-40.7M | ||
| Q1 25 | $3.3M | $-48.4M | ||
| Q4 24 | $12.4M | — | ||
| Q3 24 | $7.2M | $-41.7M | ||
| Q2 24 | $6.5M | $-80.3M | ||
| Q1 24 | $4.6M | $-53.5M |
毛利率PTLOZLAB
| Q4 25 | — | 51.0% | ||
| Q3 25 | — | 59.5% | ||
| Q2 25 | — | 60.6% | ||
| Q1 25 | — | 63.6% | ||
| Q4 24 | — | 61.5% | ||
| Q3 24 | — | 64.1% | ||
| Q2 24 | — | 64.9% | ||
| Q1 24 | — | 61.4% |
营业利润率PTLOZLAB
| Q4 25 | 5.6% | -54.6% | ||
| Q3 25 | 3.0% | -42.3% | ||
| Q2 25 | 9.3% | -50.3% | ||
| Q1 25 | 5.9% | -53.3% | ||
| Q4 24 | 7.5% | -62.6% | ||
| Q3 24 | 9.0% | -66.6% | ||
| Q2 24 | 10.0% | -76.0% | ||
| Q1 24 | 6.1% | -80.7% |
净利率PTLOZLAB
| Q4 25 | 3.4% | — | ||
| Q3 25 | 0.7% | -31.2% | ||
| Q2 25 | 4.6% | -37.3% | ||
| Q1 25 | 1.9% | -45.8% | ||
| Q4 24 | 6.7% | — | ||
| Q3 24 | 4.1% | -40.9% | ||
| Q2 24 | 3.6% | -80.2% | ||
| Q1 24 | 2.8% | -61.4% |
每股收益（稀释后）PTLOZLAB
| Q4 25 | $0.08 | $-0.05 | ||
| Q3 25 | $0.02 | $-0.03 | ||
| Q2 25 | $0.12 | $-0.04 | ||
| Q1 25 | $0.05 | $-0.04 | ||
| Q4 24 | $0.17 | $-0.09 | ||
| Q3 24 | $0.11 | $-0.04 | ||
| Q2 24 | $0.10 | $-0.08 | ||
| Q1 24 | $0.08 | $-0.05 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | — | $689.6M |
| 总债务越低越好 | $334.2M | — |
| 股东权益账面价值 | $467.8M | $715.5M |
| 总资产 | $1.6B | $1.2B |
| 负债/权益比越低杠杆越低 | 0.71× | — |
8季度趋势，按日历期对齐
现金及短期投资PTLOZLAB
| Q4 25 | — | $689.6M | ||
| Q3 25 | — | $717.2M | ||
| Q2 25 | — | $732.2M | ||
| Q1 25 | — | $757.3M | ||
| Q4 24 | — | $779.7M | ||
| Q3 24 | — | $616.1M | ||
| Q2 24 | — | $630.0M | ||
| Q1 24 | — | $650.8M |
总债务PTLOZLAB
| Q4 25 | $334.2M | — | ||
| Q3 25 | $322.6M | — | ||
| Q2 25 | $317.0M | — | ||
| Q1 25 | $319.8M | — | ||
| Q4 24 | $311.7M | — | ||
| Q3 24 | $302.2M | — | ||
| Q2 24 | $305.1M | — | ||
| Q1 24 | $321.7M | — |
股东权益PTLOZLAB
| Q4 25 | $467.8M | $715.5M | ||
| Q3 25 | $459.4M | $759.9M | ||
| Q2 25 | $458.9M | $791.7M | ||
| Q1 25 | $406.9M | $810.8M | ||
| Q4 24 | $401.1M | $840.9M | ||
| Q3 24 | $382.4M | $667.7M | ||
| Q2 24 | $370.2M | $704.2M | ||
| Q1 24 | $360.5M | $762.2M |
总资产PTLOZLAB
| Q4 25 | $1.6B | $1.2B | ||
| Q3 25 | $1.6B | $1.2B | ||
| Q2 25 | $1.6B | $1.2B | ||
| Q1 25 | $1.5B | $1.2B | ||
| Q4 24 | $1.5B | $1.2B | ||
| Q3 24 | $1.5B | $985.3M | ||
| Q2 24 | $1.4B | $987.4M | ||
| Q1 24 | $1.4B | $988.4M |
负债/权益比PTLOZLAB
| Q4 25 | 0.71× | — | ||
| Q3 25 | 0.70× | — | ||
| Q2 25 | 0.69× | — | ||
| Q1 25 | 0.79× | — | ||
| Q4 24 | 0.78× | — | ||
| Q3 24 | 0.79× | — | ||
| Q2 24 | 0.82× | — | ||
| Q1 24 | 0.89× | — |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $23.2M | $-26.0M |
| 自由现金流经营现金流 - 资本支出 | $-9.2M | $-26.7M |
| 自由现金流率自由现金流/营收 | -4.9% | -21.0% |
| 资本支出强度资本支出/营收 | 17.4% | 0.5% |
| 现金转化率经营现金流/净利润 | 3.69× | — |
| 过去12个月自由现金流最近4个季度 | $-18.5M | $-158.9M |
8季度趋势，按日历期对齐
经营现金流PTLOZLAB
| Q4 25 | $23.2M | $-26.0M | ||
| Q3 25 | $20.0M | $-32.0M | ||
| Q2 25 | $19.2M | $-31.0M | ||
| Q1 25 | $9.4M | $-61.7M | ||
| Q4 24 | $26.1M | $-55.8M | ||
| Q3 24 | $30.3M | $-26.8M | ||
| Q2 24 | $32.6M | $-42.2M | ||
| Q1 24 | $9.1M | $-90.1M |
自由现金流PTLOZLAB
| Q4 25 | $-9.2M | $-26.7M | ||
| Q3 25 | $-5.0M | $-35.0M | ||
| Q2 25 | $5.2M | $-33.9M | ||
| Q1 25 | $-9.6M | $-63.2M | ||
| Q4 24 | $-5.6M | $-58.4M | ||
| Q3 24 | $7.7M | $-28.2M | ||
| Q2 24 | $15.6M | $-42.9M | ||
| Q1 24 | $-7.9M | $-91.1M |
自由现金流率PTLOZLAB
| Q4 25 | -4.9% | -21.0% | ||
| Q3 25 | -2.7% | -30.4% | ||
| Q2 25 | 2.8% | -31.1% | ||
| Q1 25 | -5.4% | -59.9% | ||
| Q4 24 | -3.0% | -53.8% | ||
| Q3 24 | 4.3% | -27.7% | ||
| Q2 24 | 8.6% | -42.9% | ||
| Q1 24 | -4.7% | -104.5% |
资本支出强度PTLOZLAB
| Q4 25 | 17.4% | 0.5% | ||
| Q3 25 | 13.8% | 2.6% | ||
| Q2 25 | 7.5% | 2.6% | ||
| Q1 25 | 10.8% | 1.5% | ||
| Q4 24 | 17.2% | 2.4% | ||
| Q3 24 | 12.7% | 1.3% | ||
| Q2 24 | 9.3% | 0.7% | ||
| Q1 24 | 10.2% | 1.1% |
现金转化率PTLOZLAB
| Q4 25 | 3.69× | — | ||
| Q3 25 | 16.51× | — | ||
| Q2 25 | 2.21× | — | ||
| Q1 25 | 2.85× | — | ||
| Q4 24 | 2.10× | — | ||
| Q3 24 | 4.20× | — | ||
| Q2 24 | 5.03× | — | ||
| Q1 24 | 1.99× | — |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
PTLO
暂无分部数据
ZLAB
| Zejula | $56.0M | 44% |
| Other | $21.9M | 17% |
| Nuzyra | $16.0M | 13% |
| Optune | $11.9M | 9% |
| XACDURO | $10.7M | 8% |
| Qinlock | $9.7M | 8% |
| AUGTYRO | $836.0K | 1% |
